Beyond Biotech - the podcast from Labiotech
Varighed i alt:
24 h 25 min
Theialife’s race to bring a childhood myopia treatment to market
Beyond Biotech - the podcast from Labiotech
44:11
The best biotech conversations you missed this summer
Beyond Biotech - the podcast from Labiotech
40:27
Rewriting the rules of genetic medicine with tRNA therapeutics
Beyond Biotech - the podcast from Labiotech
30:48
How Evox Therapeutics is targeting CNS diseases with exosomes
Beyond Biotech - the podcast from Labiotech
31:08
BIOSPAIN 2026: partnering, policy, and the rise of Spanish biotech
Beyond Biotech - the podcast from Labiotech
34:11
Beyond biology: Nanobiotix's physics-first approach to cancer
Beyond Biotech - the podcast from Labiotech
31:21
How Cancer Research Horizons is building the future of childhood cancer medicines
Beyond Biotech - the podcast from Labiotech
43:01
Why Western pharma is sleeping on China's circular RNA revolution
Beyond Biotech - the podcast from Labiotech
36:12
Gain Therapeutics: a first-in-class, disease-modifying therapy for Parkinson's
Beyond Biotech - the podcast from Labiotech
42:03
This nonprofit is building the ecosystem to cure epidermolysis bullosa
Beyond Biotech - the podcast from Labiotech
40:12
How BIO-Europe is expanding beyond dealmaking in 2026
Beyond Biotech - the podcast from Labiotech
25:16
Turning cancer cell dependencies into targeted therapies
Beyond Biotech - the podcast from Labiotech
31:19
The first PROTAC is here. What comes next in protein degradation?
Beyond Biotech - the podcast from Labiotech
35:31
De-risking neurology drug development with better mouse models
Beyond Biotech - the podcast from Labiotech
40:32
BIO International Convention 2026: practical advice from former Evotec CEO Werner Lanthaler
Beyond Biotech - the podcast from Labiotech
40:49
Advancing corticosteroids and hormonal therapies for supply and scale
Beyond Biotech - the podcast from Labiotech
27:03
Episode 200 Special: Joachim Eeckhout on building Labiotech and the future of biotech media
Beyond Biotech - the podcast from Labiotech
43:33
World MS Day Special: Immunic reveals new hope for progressive MS
Beyond Biotech - the podcast from Labiotech
27:30
The problem at the heart of drug discovery: Lexogen & Ochre Bio on the power of AI on human data
Beyond Biotech - the podcast from Labiotech
38:49
Freeze variability, not progress: strengthen your cell therapy supply chain from the start
Beyond Biotech - the podcast from Labiotech
30:25
Making labs smarter for scientific breakthroughs
Beyond Biotech - the podcast from Labiotech
30:48
How Epicrispr is leveraging CRISPR without cutting DNA
Beyond Biotech - the podcast from Labiotech
33:03
Diagonal Therapeutics’ innovative clustering antibodies for vascular diseases
Beyond Biotech - the podcast from Labiotech
31:10
Argobio: the venture model building Europe’s next biotech champions
Beyond Biotech - the podcast from Labiotech
42:00
Multi-agent AI delivers reliable and scalable insights for single-cell omics
Beyond Biotech - the podcast from Labiotech
43:42
Nionyx Bio's kidney gene therapy wins the 2026 BIO-Europe Spring Startup Spotlight
Beyond Biotech - the podcast from Labiotech
28:35
HaemaLogiX - precision immunotherapy for multiple myeloma
Beyond Biotech - the podcast from Labiotech
43:13
How Leyden Labs is revolutionizing flu protection with its intranasal antibody spray
Beyond Biotech - the podcast from Labiotech
32:30
How to optimize your biotech company for partnering, licensing, and business success
Beyond Biotech - the podcast from Labiotech
42:23
Reversing tumor immunosuppression with next-gen GPCR modulation
Beyond Biotech - the podcast from Labiotech
34:14
Misinformation is a public health crisis - here's how to fix it
Beyond Biotech - the podcast from Labiotech
50:03
Accelerating rare disease cures with ASOs, gene editing, and AI
Beyond Biotech - the podcast from Labiotech
48:53
Using AI to crack undruggable drug targets
Beyond Biotech - the podcast from Labiotech
32:58
How Eli Lilly's biotech collaboration model is rewriting early-stage innovation
Beyond Biotech - the podcast from Labiotech
35:46
Building a smart oncology pipeline with Cumulus Oncology
Beyond Biotech - the podcast from Labiotech
34:42
Top 5 trends that will drive biopharma in the next decade with Tim Opler
Beyond Biotech - the podcast from Labiotech
36:25
Labiotech's 15 biopharma companies to watch in 2026
Beyond Biotech - the podcast from Labiotech
41:28
M Ventures: pharma CVC and biotech innovation in 2026
Beyond Biotech - the podcast from Labiotech
35:43
Johnson & Johnson’s hematology portfolio: breakthroughs to watch
Beyond Biotech - the podcast from Labiotech
34:25
Tackling pulmonary fibrosis: Boehringer Ingelheim’s new drug + AI approach
Beyond Biotech - the podcast from Labiotech
38:47
